Inventor

ARMITAGE RICHARD J

US35 patents

⚠️ This page may combine multiple inventors who share the name “ARMITAGE RICHARD J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARMITAGE RICHARD J

IMMUNEX CORP

CD40 ligand polypeptide

Method of preventing or treating disease characterized by neoplastic cells expressing CD40

CD30 ligand

Methods and compositions relating to anti-interleukin-4 receptor antibodies

Methods of inhibiting CD40L binding to CD40 with soluble monomeric CD40L

Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same

DNA encoding CD40 ligand, a cytokine that binds CD40

DNA encoding CD40 ligand, a cytokine that binds CD40

Monoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the same

Antibodies directed against CD30 ligand

CD27 ligand

Detection of mutations in a CD40 ligand gene

CD40-Ligand lacking native-pattern glycosylation

Method of augmenting a vaccine response by administering CD40 ligand

CD30 ligand oligomers and polypeptides

ULBP antibodies

Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules

CD30 ligand

CD30 ligand conjugates

Anti-interleukin-4 receptor antibodies

Treatment of individuals exhibiting defective CD40L

Isolated Epstein-Barr virus BZLF2 proteins that bind MHC class II βchains

Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains

Mouse CD40 ligand-specific antibodies and hybridomas

Interleukin-4 binding protein-γ

CD30 ligand

Defective CD4+T-cells that express active CD40-L

AMGEN INC

BCMA antigen binding proteins

BCMA Antigen binding proteins

BCMA antigen binding proteins

(unassigned)

Antibodies to CD40

Use of CD40 ligand, a cytokine that binds CD40, to stimulate hybridoma cells

ARMITAGE RICHARD J

Anti-interleukin-4 receptor antibodies

NOVO NORDISK AS

Human CD30 ligand antigen binding proteins

COSMAN DAVID J

ULBP2 polypeptides